You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-HDAC-OBP-801
OBP-801

Chemical Structure : OBP-801

CAS No.: 328548-11-4

OBP-801 (OBP801;YM 753;Spiruchostatin A)

Catalog No.: PC-61957Not For Human Use, Lab Use Only.

OBP-801 (YM 753;Spiruchostatin A) is a novel cyclic-peptide-based HDAC inhibitor with IC50 of 2 nM.

Packing Price Stock Quantity
100 mg Get quote
250 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

OBP-801 (YM 753;Spiruchostatin A) is a novel cyclic-peptide-based HDAC inhibitor with IC50 of 2 nM; significantly inhibits the cell growth on comparison with each agent alone and synergistically increased apoptosis with the induction of Bim; significantly suppresses tumor growth in vivo.

Kidney Cancer

Phase 1 Clinical

Physicochemical Properties

M.Wt 473.603
Formula C20H31N3O6S2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(1S,5S,6R,9S,20R,E)-5-hydroxy-6-isopropyl-20-methyl-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docos-15-ene-3,8,18,21-tetraone

References

1. Shindoh N, et al. Int J Oncol. 2008 Mar;32(3):545-55.

2. Yoshioka T, et al. Gynecol Oncol. 2013 May;129(2):425-32.

3. Furutani A, et al. Oncol Res. 2014;21(5):281-6.

4. Akiyama M, et al. Oncol Res. 2017 Sep 21;25(8):1245-1252.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: